Beijing Strong Biotechnologies Receives Medical Device Registration for Thyroxine Uptake Assay Kit
Stock News
Jun 03
Beijing Strong Biotechnologies, Inc. (ASX: 300406) has announced that it has received a Medical Device Registration Certificate from the Beijing Medical Products Administration for its Thyroxine Uptake Assay Kit, which utilizes magnetic particle chemiluminescence immunoassay technology.
This kit is designed for the in vitro quantitative determination of thyroxine uptake (T-Uptake) in human serum or plasma.
The acquisition of this registration certificate enriches the company's product portfolio within the specialized field of in vitro diagnostic chemiluminescence.
This development is expected to enhance the company's core competitiveness and market expansion capabilities, positively impacting its future business operations.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.